Literature DB >> 6794924

Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin-C treatment.

G Agnelli, P Gresele, G G Nenci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6794924     DOI： 10.1007/BF00258482

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  4 in total

1.  Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.

Authors:  S Krauss; T Sonoda; A Solomon
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

2.  Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin-C.

Authors:  K D Lempert
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

3.  Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil.

Authors:  S C Gulati; P Sordillo; S Kempin; L Reich; G B Magill; E Scheiner; B Clarkson
Journal:  Cancer       Date:  1980-05-01       Impact factor: 6.860

4.  Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C.

Authors:  B G Jones; J W Fielding; C E Newman; A Howell; V S Brookes
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.